Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany · Delayed Price · Currency is EUR 0.0038
+0.0002 (5.56%)
At close: Nov 28, 2025
FRA:9RP Market Cap
FRA:9RP has a market cap or net worth of €5.27 million as of December 1, 2025. Its market cap has increased by 210.35% in one year.
Market Cap
5.27M
Enterprise Value
3.75M
Revenue
79.69K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since March 1, 2021, FRA:9RP's market cap has decreased from 9.62M to 5.27M, a decrease of -45.26%. That is a compound annual growth rate of -11.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 5.27M | 252.55% |
| Dec 30, 2024 | 1.49M | -69.44% |
| Dec 29, 2023 | 4.89M | 240.47% |
| Dec 30, 2022 | 1.44M | -76.76% |
| Dec 30, 2021 | 6.18M | -35.79% |
| Mar 1, 2021 | 9.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |